U.S., Dec. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07271069) titled 'Effectiveness of Ozanimod in Patients With Steroid-Dependent Ulcerative Colitis' on Nov. 27.
Brief Summary: The purpose of this study is to evaluate the effectiveness and safety of ozanimod vs azathioprine for the treatment of ulcerative colitis (UC) in real-world clinical practice in Japan
Study Start Date: Feb. 28, 2026
Study Type: OBSERVATIONAL
Condition:
Ulcerative Colitis (UC)
Intervention:
DRUG: Ozanimod
According to the product label
DRUG: Azathioprine
According to the product label
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Bristol-Myers Squibb
Disclaimer: Curated by HT Syndication....